CytomX Therapeutics to Announce First Quarter 2019 Financial Results

    NEXT STORY
    Corbus Pharmaceuticals Completes Enrollment of RESOLVE-1 Phase 3 Study of Lenabasum for Treatment of Systemic Sclerosis
    PREV STORY
    Kiniksa Reports First Quarter 2019 Financial Results and Highlights Recent Corporate and Pipeline Activity
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Atreca Reports First Quarter 2020 Financial Results and Recent Corporate Developments

    author_avatar
    NASDAQ Market News

    BioCorRx Promotes Dr. Balbir S. Brar to Senior VP of Drug Development; Extends Service Agreement

    author_avatar
    NASDAQ Market News

    PositiveID Updates Report for its Molecular Diagnostics, Mobile Labs and Medical Device Businesses with Addressable Markets Exceeding $30 Billion

    DELRAY BEACH, Fla., April 24, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) ...

    author_avatar
    NASDAQ Market News